Mycotoxins nivalenol and deoxynivalenol differently modulate cytokine mRNA expression in Jurkat T cells. by L. SEVERINO et al.
www.elsevier.com/locate/issn/10434666
Cytokine 36 (2006) 75–82Mycotoxins nivalenol and deoxynivalenol diﬀerentially
modulate cytokine mRNA expression in Jurkat T cells
Lorella Severino a, Diomira Luongo a,b, Paolo Bergamo b, Antonia Lucisano a,
Mauro Rossi b,*
a Department of Pathology and Animal Health, Division of Toxicology, University of Naples ‘‘Federico II’’, via Delpino 1, 80137 Naples, Italy
b Istituto di Scienze dell’Alimentazione, CNR, via Roma 52, 83100 Avellino, Italy
Received 21 July 2006; received in revised form 25 October 2006; accepted 2 November 2006Abstract
Deoxynivalenol (DON) and its hydroxylated form nivalenol (NIV) are Fusarium mycotoxins that occur in cereal grains alone or in
combination. Several studies have shown that these metabolites aﬀect lymphocyte functions. However, the molecular mechanisms
underlying their activities are still partially known. To address this issue, we examined the inﬂuence of NIV and DON in modulating
IFNc, IL-2 and IL-8 mRNA levels in Jurkat T cells. In PMA/ionomycin stimulated cells, pre-incubated with increasing concentrations
of NIV, transcription was induced in the range 0.06–2 lM; higher concentrations of NIV were found non-stimulating (4 lM) or
inhibitory (8 lM) for IFNc and IL-2 whereas IL-8 was still induced. DON administration elicited a similar proﬁle for IL-8 and IFNc,
whilst IL-2 mRNA was induced in a broader range of concentrations. Combination of NIV and DON at 1:1 and 1:10 ratios essentially
restored the cytokine transcriptional pattern observed with NIV alone but the level of transcripts, with the exception of IL-8, peaked at
lower concentrations suggesting interactive eﬀects. Moreover both mycotoxins caused inhibition of cell proliferation, mediated by
induction of apoptosis, conﬁrming previous results and highlighting the usefulness of Jurkat as a T-cell model to study the eﬀects of
mycotoxins on the immune functions in humans.
 2006 Elsevier Ltd. All rights reserved.
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Nivalenol (NIV) and deoxynivalenol (DON)1 are myco-
toxins produced by soil fungi of the Fusarium genus which
are abundant in many cereal crops in the ﬁeld (wheat,
maize, barley, oats and rye) and also in processed grains
(malt, beer and bread). A recent data collection on the
occurrence of Fusarium toxins in food in the European1043-4666/$ - see front matter  2006 Elsevier Ltd. All rights reserved.
doi:10.1016/j.cyto.2006.11.006
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E-mail address: mrossi@isa.cnr.it (M. Rossi).
1 Abbreviations used: DON, deoxynivalenol NIV, nivalenol; IL-2,
interleukin-2; IFNc, interferon-c; FBS, foetal bovine serum; PCR,
polymerase chain reaction; cpm, counts per minute; PMA, phorbol 12-
myristate 13-acetate; AMC, 7-amino-4-methylcoumarin; Ac-DEVD-
AMC, acetyl Asp-Glu-Val-Asp 7-amido-4-methylcoumarin; LDH, lactate
dehydrogenase; NAD, nicotinamide adenine dinucleotide; NP-40,
Nonidet P-40.Union showed a 57% incidence of positive samples for
DON and 16% for NIV out of several thousands of
samples analysed [1].
Chemically, NIV (12,13-epoxy-3,4,7,15-tetrahydroxy-
trichothec-9-en-8-one) and DON (12,13-Epoxy-3,4,15-tri-
hydroxytrichothec-9-en-8-one) belong to the trichothecenes
group, very stable compounds both during storage/milling
and processing/cooking of food [2].
Diﬀerent toxic properties have been associated to tri-
chothecenes. In particular a series of studies with experi-
mental animals demonstrated eﬀects on the immune
system, including impaired delayed-type hypersensitivity
responses, phagocyte activity [3–5] and modulation of host
response to enteric infections [6]. In particular, NIV inhib-
ited total and antigen speciﬁc IgE production in ovoalbu-
min speciﬁc T-cell receptor ab transgenic mice [7]. In
vitro analyses showed that trichothecenes can both
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blastogenesis in cultured human lymphocytes producing
50% inhibition of thymidine incorporation in mitogen-
stimulated human peripheral lymphocytes [9]. Thuvander
et al. [10] found that NIV inhibited proliferation of human
male and female mitogen-stimulated lymphocytes. DON
instead induced inhibition of human lymphocyte prolifera-
tion and did have signiﬁcant eﬀects on cytokine proﬁles, in
particular there was a marked increase in IL-2 production,
a modest increase in both IL-4 and IFNc and, in contrast,
an inhibition of IL-6 production [10]. In another study,
DON was shown to induce IL-2, IL-4 and IL-5 production
[11]. Some other studies indicated that trichotecenes induce
apoptosis in cells [3,12,13]. More in particular, Shifrin et al.
[14] found that NIV and DON were, respectively, interme-
diate and strong inducers of apoptosis in Jurkat cells.
Among biochemical eﬀects ascribed to NIV and DON,
inhibition of protein synthesis was reported [15] mediated
by speciﬁc blocking of peptidil transferase activity [16]. Ini-
tiation of a ‘ribotoxic stress response’ by protein synthesis
inhibitors has been postulated to be a signal for MAPKs
activation [17]; interestingly, DON was shown to induce
MAPK phosphorylation in Jurkat cells paralleled by
induction of apoptosis and cytokine production [18].
Several mycotoxins are commonly present in food.
However there is relatively little information about the
interaction between concomitantly occurring trichothec-
enes and the consequences for their immunotoxicity. Some
recent studies focused on the combined administration of
trichothecenes in in vitro test systems showing that co-oc-
currence of toxins can exert interactive eﬀects [19]. The pur-
pose of this study was to further elucidate the activity of
NIV and DON, alone and in combination, on cytokine
mRNA expression in Jurkat cells, a model of human T
lymphocyte, to gain more information about the immune
eﬀects exerted by these toxins and, more in particular, to
deﬁne the minimal doses able to modulate the cell system.
2. Materials and methods
2.1. Reagents
RPMI-1640 medium, L-glutamine, streptomycin, peni-
cillin, foetal bovine serum (FBS) and non-essential
aminoacids were purchased from Cambrex BioproductsTable 1
Primer sequences
L-32 Sense 50-CCT C
Anti-sense 50-GCC C
IL-2 Sense 50-AAC T
Anti-sense 50-TTC CT
IFNc Sense 50-TCA G
Anti-sense 50-GTT C
IL-8 Sense 50-ATGAC
Anti-sense 50-TCTCAEurope (Verviers, Belgium). Deoxynivalenol (D-0156),
Nivalenol (N-7769) and reagents for LDH assay were
from Sigma (St. Louis, MO, USA). Caspase 3 substrate,
acetyl Asp-Glu-Val-Asp 7-amido-4-methylcoumarin (Ac-
DEVD-AMC), and caspase 3 standard, 7-amino-4-meth-
ylcoumarin (AMC), were purchased from Calbiochem
(San Diego, CA, USA). TRIZOL and all other reagents
used for reverse transcription, PCR ampliﬁcation and
gel electrophoresis were from Invitrogen Ltd (Paisley,
UK).
2.2. Cell culture
Jurkat T cells (ATCC, Manassas, VA) were grown at
37 C in a humidiﬁed atmosphere consisting of 5% CO2/
95% air in RPMI-1640 medium supplemented with 10%
(v/v) heat-inactivated FBS, 2 mM L-glutamine, 100 U/ml
penicillin, 100 lg/ml streptomycin, and 1% (w/v) non-es-
sential amino acids. Cells were kept in the exponential
growth phase by passages at 2–3 days intervals.
2.3. Measurement of cytokine mRNA levels
The expression of cytokine mRNAs in the Jurkat cell
line was assessed by semi-quantitative reverse transcrip-
tion-polymerase chain reaction (RT-PCR). Brieﬂy, cells
were cultured in 24-well plate (2 · 106/well) and incubated
for 24 h with diﬀerent concentrations of DON and NIV, in
the presence/absence of 1 lg/L PMA and 0.5 lM ionomy-
cin [20]. At the end of the incubation, total RNA was iso-
lated from cells using TRIZOL reagent according to the
manufacturer’s protocol. Reverse transcription of 1 lg
RNA was primed using oligo-(dT)12–18 and diﬀerent ali-
quots of cDNA were then used for PCR using 1 U of
Taq DNA polymerase and 20 pmoles of each primer. The
thermo-ampliﬁcation program consisted of an initial dena-
turation (5 min at 94 C), followed by 28–35 cycles of 1 min
denaturation (94), 1 min annealing at 60 C (IL-8), 54 C
(L-32) or 52 C (IL-2 and IFNc) and 30 s elongation at
72 C with a ﬁnal 5 min extension period at 72 C. The oli-
gonucleotides used for ampliﬁcation and the size of the
PCR products are described in Table 1. In preliminary
experiments we found that L-32 gene [21] expressed tran-
script levels more comparable to the cytokine mRNAs con-
tent than of other commonly used housekeeping genes (notAG ACC CCT TGT GAA GC-30 145 bp
TT GAA TCT TCT ACG AAC C-3 0
CA CCA GGA TGC TCA CAT TTA-30 148 bp
G GGT CTT AAG TGA AAG TTT-3 0
CT CTG CAT CGT TTT GG-30 120 bp
CA TTA TCC GCT ACA TCT GAA-30
TTCCAAGCTGGCCGTGGCT-30 289 bp
GCCCTCTTCAAAAACTTCTC-3 0
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using the software Lasergene Primerselect (DNASTAR
Inc., Madison, Wisconsin, USA) so that ampliﬁed cDNA
fragments sizes could be readily distinguished from those
obtained from genomic DNA, if present. Negative control
was performed by omitting RNA from the cDNA synthesis
and speciﬁc PCR ampliﬁcation. PCR products were ana-
lysed on a 2% (w/v) agarose gel stained with VISTRA
Green (Amersham International plc, Buckinghamshire,
UK). Fluorescence scanning and quantitative analysis of
detected bands were carried out on STORM 860 system
by IMAGEQUANT software (Molecular Dynamics, Inc.,
Sunnyvale, CA). Results were expressed as cytokine/L-32
mRNA ratio.
2.4. Cell proliferation assay
Cells were cultured in ﬂat bottom 96-well plates (2 · 104/
well) for 24 h in the presence of diﬀerent concentrations of
DON (0.0625–80 lM) and NIV (0.0625–8 lM). Eighteen
hours prior to harvesting cells were pulsed with 1 lCi/well
[3H]-thymidine. Cultures were harvested on ﬁlters using a
semiautomatic cell harvester (Filtermate, Packard, Dan-
vers, MA). [3H]-thymidine incorporation was assessed by
a microplate liquid scintillator (Top Count NXT, Pack-
ard, Danvers, MA). Results were expressed as cpm (counts
per minute).
2.5. Apoptosis assay
Caspase-3 activity was measured by determining the
release of 7-amino-4-methylcoumarin (AMC), following
enzyme hydrolysis of acetyl Asp-Glu-Val-Asp 7-amido-4-
methylcoumarin (Ac-DEVD-AMC). Cells (6 · 105/well)
were incubated with diﬀerent concentrations of DON and
NIV for 24 h in 48-well plates, then washed with PBS
and resuspended in 100 ll lysis buﬀer (50 mM Hepes, pH
7.4, 5 mM CHAPS, 5 mM DTT) for 20 min at 4 C.
Lysates were centrifuged (10,000g, for 5 min at 4 C) and
supernatant aliquots incubated with reaction buﬀer (lysis
buﬀer supplemented with 2 mM EDTA and 50 lM Ac-
DEVD-AMC) for 60 min at 37 C. Fluorescence data
(360EX/460EM) were recorded and used to calculate the
concentration of released AMC by means of calibration
curve with pure standard. The caspase-3 activity was ﬁnally
expressed as nmoles of AMC/mg protein. Cells treated
with 10 lM actinomycin D were used as positive control.
2.6. Cytotoxicity assay
Lactate dehydrogenase (LDH) was used as in vitro
marker for cellular toxicity [22]. Cells were incubated at
2 · 105/well in 48-well plates with diﬀerent doses of DON
and NIV for 24 h. After 20 min at 4 C the cell suspensions
were centrifuged (4000g, 5 min., 4 C). The supernatants
were recovered, whereas the cell pellets were lysed in
100 ll of 0.2 M Tris/HCl pH 8.0, containing 1% (w/v)Nonidet P-40 (NP-40), for 30 min. at 4 C. Lysates and
supernatant aliquots (100 ll) were then incubated with
100 ll reaction buﬀer (0.7 mM p-iodonitrotetrazolium vio-
let, 50 mM L-lactic acid, 0.3 mM phenazine methosulphate,
0.4 mMNAD, 0.2 M Tris/HCl pH 8.0) for 30 min at 37 C.
Absorbance was read at 490 nm; results were expressed as
percentage of total LDH release from control cultures
treated with 1% (w/v) NP-40 and calculated as follows:
[(experimental value  blank value)/(total lysis  blank
value) · 100].
2.7. Statistical analysis
The results were expressed as means ± SD. Diﬀerences
among the various treatment groups were determined by
one-way analysis of variance (ANOVA). Multiple compar-
ison of treatment means were made using the Tukey test.
The criterion for signiﬁcance was P < 0.05 for all studies.
3. Results
3.1. Assessment of NIV and DON treatments on cytokine
mRNA expression
ELISA experiments indicated that DON, but not NIV,
induced IL-2 and IL-8 protein secretion in Jurkat cells
[18]. Starting from this point we investigated the minimal
concentration of NIV and DON aﬀecting the mRNA pro-
ﬁle of these cytokines and of IFNc, as we reported that in
Jurkat this pro-inﬂammatory molecule can be modulated
by mycotoxins [23]. Transcript levels were evaluated by
semi-quantitative RT-PCR, after normalization to the
mRNA content of the housekeeping gene L-32. As expect-
ed, cytokine mRNA production could be detected only fol-
lowing cell stimulation with PMA/ionomycin, whereas
L-32 levels were similar in unstimulated and stimulated
cells (Fig. 1). On the other hand, incubation of mycotoxins
in the full range 0.06–8 lM with unstimulated cells did not
evidence any transcript (data not shown). In stimulated
cells, pre-incubated with increasing concentrations of
NIV, the levels of both IFNc, IL-2 and IL-8 mRNA pro-
gressively increased and peaked at 1–2 lM whereas higher
concentrations of NIV were found less stimulating (4 lM)
or inhibitory (8 lM) for the examined Th1-type cytokines;
on the contrary, IL-8 was induced in almost all the concen-
tration range (Fig. 1). Similarly, DON induced the expres-
sion of IL-8 and IFNc mRNAs; nevertheless, the latter
appeared to peak later and with a lower increase than that
reported for NIV (Fig. 1). Very interestingly, this mycotox-
in appeared to diﬀerently aﬀect IL-2 mRNA levels; in fact,
raising concentrations of DON were paralleled by a con-
stant increase of IL-2 transcripts, with no evidence of a
dose-dependent diﬀerential activity. The analysis of RT-
PCR data pooled from diﬀerent experiments more accu-
rately revealed that IFNc mRNA peaked at 1 lM NIV
(fourfold increase) and 4 lM DON (threefold; Fig. 2); sim-
ilarly IL-2 transcripts peaked at 1 lM NIV (threefold
Fig. 2. Densitometric analysis of cytokine mRNAs. Scanning of ﬂuores-
cent bands was carried out and each cytokine value, normalized to the
relative content of L-32, was expressed as cytokine/L-32 mRNA ratio.
Results represent mean ± SD of three independent experiments. *Diﬀerent
from DON (NIV); #diﬀerent from DON (mixture); §diﬀerent from NIV
(mixture); P < 0.05.
Fig. 1. Assessment of NIV and DON treatment on cytokine mRNA expression. Jurkat T cells, stimulated with PMA/ionomycin, were treated with
diﬀerent doses of NIV and DON, alone or in combination (1:1 ratio), for 24 h. mRNA levels of IL-2, INFc, IL-8 and the housekeeping gene L-32 were
assessed by a semiquantitative RT-PCR; the products were then analysed on a 2.0% agarose gel.
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with a fourfold increase. For IL-8 mRNA a twofold
increase was registered for both mycotoxins in the range
2–8 lM (Fig. 2).
The eﬀects of NIV and DON co-incubation, with
increasing concentrations of the two mycotoxins, were thenexamined. Combination of NIV and DON (1:1 ratio)
essentially restored the IL-2 mRNA proﬁle observed with
NIV alone, but the level of transcript peaked at lower con-
centrations (Fig. 1), suggesting an interactive eﬀect exerted
by the two mycotoxins. Very interestingly, at higher con-
centration the inhibitory eﬀect of NIV prevailed over the
inductive activity of DON. In the same way, the IFNc pro-
ﬁle following co-administration of NIV and DON still
reﬂected that observed with NIV alone while IL-8 mRNA
expression was normally induced. The densitometric
assessment showed that IL-2 mRNA peaked at 0.5 lM
NIV plus 0.5 lM DON (threefold increase; Fig. 2); for
IFNc the induction proﬁle was similar to that observed
in the presence of NIV alone but the mRNA levels were
found lower; IL-8 levels essentially reﬂected those regis-
tered for the single mycotoxins (Fig. 2). Considering that
in ﬁeld samples the concentration of DON is often found
higher than NIV [24] we also analysed the combined eﬀect
of the two mycotoxins in the presence of DON overload
(1:10; NIV:DON ratio). As reported in Fig. 3, higher con-
centrations of DON still induced a 2- to 3-fold increase in
the expression of IL-8 and IFNc mRNAs; on the other
hand DON was found inhibitory for the transcription of
IL-2 starting from 40 lM. Co-incubation at the 1:10 ratio
essentially conﬁrmed the results previously reported for
the 1:1 ratio; in particular, inhibition of IFNc and a trend
to further decrease IL-2 mRNA levels were registered start-
ing from the 2:20 lM combination. Interestingly, full
induction of IL-8 was observed at all the examined
concentrations.
3.2. The eﬀects of NIV and DON on cell vitality
Jurkat cells, incubated with diﬀerent concentrations of
NIV and DON, ranging from 0.0625 to 8 lM, showed a
decrease in thymidine incorporation for both mycotoxins
(Fig. 4A); such a decrease became signiﬁcant and dose-de-
pendent at 0.5 and 1 lM for NIV and DON. Co-incuba-
tion caused a further dose-dependent decrease of cell
proliferation both at the 1:1 (Fig. 4A) and 1:10 ratio (not
shown).
Fig. 3. Cytokine mRNAs in Jurkat following co-incubation with NIV and
DON (1:10 ratio). Stimulated Jurkat T cells were treated with diﬀerent
doses of DON in the range from 10 to 80 lM, alone or in combination
with NIV at 1:10 ratio for 24 h. mRNA levels of IL-2, INFc, IL-8 and
L-32 were assessed by RT-PCR. Fluorescent bands were analysed as in
Fig.3. Results represent mean ± SD of three independent experiments.
*diﬀerent from DON alone; P < 0.05.
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proliferation was associated with apoptosis induction at
all the various examined doses, the activity of caspase 3
was determined. Exposure of cells to increasing concentra-
tions of both mycotoxins resulted in a dose-dependent raise
of caspase 3 activity, compared to untreated cells (Fig. 4B).
At 8 lM we were not able to estimate the enzyme speciﬁc
activity due to the very low cell recovery. Similar levels
of activity were still observed following co-incubation of
NIV and DON at 1:1 ratio. Next we evaluated the eﬀects
of mycotoxins on cell integrity by measuring the LDH
release in the spent medium. Results showed that NIV
and DON treatment caused a slightly and non-statistically
signiﬁcant increase of LDH activity (Fig. 4C). Again,
co-administration of mycotoxins did not signiﬁcantly
modify the levels of the released enzyme both at the 1:1
(Fig. 4 C) and 1:10 ratio (not shown).4. Discussion
In the present study we provided new insight into how
mycotoxins NIV and DON, frequently found in food,
might modulate human T-cell functions. To address this
issue the Jurkat T-cell line was used as a lymphocyte mod-
el. Jurkat cells have extensively been used for diﬀerent
immunological studies. They have proved helpful, particu-
larly for the dissection of the IL-2 and Ag-receptor struc-
tures, as well as molecules of signal transduction. The use
of Jurkat cell culture oﬀers several advantages over other
methods for the assessment of immunotoxicity; for
instance, present analytical systems, mainly based on phys-
ical–chemical evaluations, do not take into account for a
given mycotoxin interaction with other mycotoxins. On
the other hand, it is known that the capacity of diﬀerent
transduction pathways to react to external stimuli is
altered in Jurkat in comparison with normal T cells [25];
consequently, results gained in Jurkat needs careful
interpretation before to extrapolate them to the normal
T-cell biology. In particular our data were in line with
previous results on normal T lymphocytes [9–11,13], so
conﬁrmimg the validity of this in vitro cell model for
studying mycotoxins.
It must be emphasised that the actual doses required for
human eﬀects represent a major concern in studies on
mycotoxins. Thus, our work was initially focussed on the
identiﬁcation of the minimal concentrations of NIV and
DON suﬃcient for modulating cytokine production. To
date there are no studies which have investigated the activ-
ities of NIV and DON at the mRNA cytokine level in
human lymphocytes. Interestingly, we found that these
mycotoxins diﬀerentially inﬂuenced the examined Th1-type
cytokine transcripts. In particular NIV appeared to exert a
dual eﬀect, inductive at low doses (0.06–2 lM) and sup-
pressive at higher concentration (8 lM). The inductive
eﬀect may be explained by assuming that, in analogy with
other trichothecenes [18,26], NIV can increase the binding
activity of the transcription nuclear factors NF-jB and AP-
1 via MAPK activation. We speculated that the reduced
levels of IFNc and IL-2 transcripts at 8 lM are instead
due to activation of speciﬁc inhibitory pathways. In fact,
inhibition of the overall protein synthesis by NIV cannot
be claimed to explain this result, as transcriptional up-reg-
ulation of IL-8 was reported at the very same NIV concen-
tration. Experiments are in progress in our lab to better
elucidate this aspect. Apparently, our results are in contrast
with ELISA data describing no variation of IL-2 and IL-8
protein content in the supernatants of NIV-treated Jurkat
cell cultures in comparison with that of untreated cells, at
NIV concentration we reported to be inductive [18]. This
divergence may well found explanation assuming diﬀerenc-
es in assay sensitivity (RT-PCR vs ELISA), as well as the
consequence of a still undeﬁned post-transcriptional NIV
activity.
Conversely our data on the modulation activity of DON
on IL-2 and IL-8 transcripts were in agreement with
Fig. 4. Eﬀects of NIV and DON on Jurkat cell vitality. Jurkat T cells were cultured for 24 h in the presence of increasing concentrations of NIV and DON,
tested alone and in combination (1:1 ratio), at concentrations ranging from 0.06 to 8 lM. (A) DNA synthesis was measured by [3H]-thymidine
incorporation and expressed as cpm. (B) For assessment of apoptosis induction, caspase-3 activity was analysed and values calculated as nmoles AMC/mg
protein; cells treated with 10 lM actinomycin D were used as positive control. (C) Cytotoxicity of mycotoxins was assessed by determining the activity of
LDH released into the medium; data were expressed as percentage of LDH released from the positive control (cells treated with 1% NP-40). Each value
represents the mean ± SD of three independent experiments. Ctr, control, cells incubated in the absence of mycotoxins. *diﬀerent from non-treated cells.
#Diﬀerent from NIV- and DON-treated cells; P < 0.05.
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levels of the two cytokines in Jurkat cells [18]. Accordingly,
we also found DON-mediated induction of IFNc, but low-
er than that reported for NIV. Interestingly, DON and
NIV induced a completely diﬀerent eﬀect on IFNc and
IL-2 transcripts at high concentration. In particular, we
found that NIV was inhibitory while DON was inductive
at 8 lM. The inductive eﬀect was lost at concentration
higher than 40 lM. If we consider that the two trichothec-
enes have a similar sesquiterpenoid structure, diﬀering only
for one more OH- group hold in position 7 by NIV, togeth-
er our data indicate that this chemical diﬀerence plays arole at 8 lM concentration, driving a well deﬁned ﬁne-
tuning of the lymphocyte immune functions. In particular,
the ability of DON to up-regulate IL-2 mRNA is in line
with other results in murine T cells [26,27] and represent a
very important clue, considering the central role of this
cytokine in modulating T-cell development in physiological
and inﬂammatory conditions. Moreover, DON-induced IL-
2 overproduction may change the dynamics of proliferating
lymphocytes with implications for development of autoim-
mune diseases [28,29]. As underlined above T-cell cytokine
synthesis can be also modulated by post-transcriptional
mechanisms such as stabilisation of cytokine mRNA
L. Severino et al. / Cytokine 36 (2006) 75–82 81through activation of various kinase pathways [30].
This possibility has been suggested to explain superinduc-
tion of IL-2 gene expression by DON in murine EL-4 thy-
moma cells [27]. Accordingly the inﬂuence of NIV and
DON on cytokine mRNA stability in Jurkat remains anoth-
er point to be addressed.
An important concern to human health is represented by
the consumption of plant products usually containing con-
comitantly diﬀerent mycotoxins. Among the several combi-
nations that frequently occur, NIV and DON are often
mentioned [31]. So we used our in vitro system to analyse
the eﬀect of mycotoxin co-incubation on the cytokine
transcription at 1:1 and 1:10 (NIV:DON) ratios. At lower
concentration (0.06–4 lM) our data suggested an interac-
tive eﬀect for IFNc and IL-2, in agreement with our prolif-
eration studies. Interestingly, at 8 lM the eﬀect of NIV
prevailed, suggesting that NIV can be considered a compet-
itive inhibitor of DON, acting on the same pathway for
modulating the IFNc and IL-2 mRNA expressions. This
property of NIV was also maintained at a 1:10 ratio. Studies
are in progress in our lab to identify this biochemical route.
For IL-8 the mRNA proﬁle following co-administration of
NIV and DON at both examined ratios conﬁrmed the
inductive eﬀect of these mycotoxins with no further
enhancement as a consequence of co-administration.
Cell proliferation studies showed inhibition exerted by
both mycotoxins. This ﬁnding is in close agreement with
other studies [10,13] that identify trichothecenes as potent
inhibitors of proliferation. This eﬀect can be related to
the capacity of the compounds to bind ribosomes and
inhibit protein synthesis [15,32]. We evidenced that this
inhibition can be exerted in vitro at very low concentrations
(0.5 and 1 lM for NIV and DON, respectively) consistent
with the levels that can be found in the tissues of treated
mice [33]. Interestingly, combination of NIV and DON
produced eﬀects in our lymphocyte proliferation test, sug-
gesting interaction between the two mycotoxins, as co-ad-
ministration further lowered cell growth, still in
accordance with other studies [10,19]. We conﬁrmed that
inhibition of cell proliferation is essentially mediated by
apoptosis, in agreement with previous studies of several tri-
chothecenes [18,33,34] and suggestive of a cellular stress
derived by the interaction with these mycotoxins. In partic-
ular, a prolonged activation of p38 was reported for DON
[33] and it is known that longer activation of MAPK can
lead to expression of genes critical for apoptosis induction
[35].
In conclusion, the ﬁndings from this study highlight the
potential immunomodulatory eﬀects of NIV and DON at
diﬀerent concentrations on a model of human lymphocyte.
The assessment of mRNA transcription showed diﬀerent
eﬀects of NIV and DON in modulating Th1-type cyto-
kines, depending on the dose whereas trichothecenes were
found to interact and inhibit lymphocyte proliferation
through apoptosis. Future work will be addressed to dis-
sect the intracellular pathways involved to gain further
information about the immunotoxicity of trichothecenes,in the perspective to more accurately state safety levels
for humans.
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